Skip to main content

Peer Review reports

From: The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy

Original Submission
22 Jul 2020 Submitted Original manuscript
7 Oct 2020 Author responded Author comments - Seo Ree Kim
19 Aug 2020 Reviewed Reviewer Report
30 Aug 2020 Reviewed Reviewer Report
Resubmission - Version 2
7 Oct 2020 Submitted Manuscript version 2
7 Dec 2020 Author responded Author comments - Seo Ree Kim
2 Nov 2020 Reviewed Reviewer Report
22 Nov 2020 Reviewed Reviewer Report
Resubmission - Version 3
7 Dec 2020 Submitted Manuscript version 3
Publishing
11 Dec 2020 Editorially accepted
5 Jan 2021 Article published 10.1186/s12885-020-07727-y

You can find further information about peer review here.

Back to article page